Latest News
DXC Technology Shares Tumble 23% on Weak Revenue Outlook and AI Turnaround Doubts
DXC Technology shares fell 23% after forecasting further organic revenue declines and reporting a GAAP loss, casting doubt on its AI-driven turnaround amid weak demand.
Main Street Capital Shares Slide on Q1 Earnings Miss Amid Dividend Coverage Concerns
Main Street Capital shares fell 4.5% after Q1 earnings missed estimates, raising questions about dividend sustainability amid credit quality concerns.
Moderna Jumps 10% on Hantavirus Vaccine Push as Cruise Ship Outbreak Revives mRNA Hopes
Moderna shares rose 10% on Friday after the company revealed early-stage work on a hantavirus vaccine, spurred by a deadly Andes virus outbreak on the MV Hondius cruise ship.
Wynn Resorts Shares Slide on UAE Delay and $900M Macau Expansion
Wynn Resorts stock dropped 6.7% Friday despite beating Q1 profit estimates, as a delayed UAE opening and a $900M+ Macau expansion raised capital concerns.
Motorola Solutions Shares Fall 11% Despite Lifted 2026 Guidance
Motorola Solutions raised its 2026 revenue forecast to $12.8B after a solid Q1, but shares tumbled 11% as investors wanted a bigger boost.
MaxLinear Stock Surges Past $100 on AI Data Center Demand Ahead of Key Vote
MaxLinear shares surged over 21% to $101.20, driven by AI demand. A shareholder vote on expanding the equity plan is set for May 20.
Arbor Realty Trust Plunges After Dividend Cut and Weak Q1 Results
Arbor Realty Trust cut its dividend to $0.17 and reported Q1 net income of just $629,000, sending shares down 11% as investors focus on troubled loans.
Dell Stock Surges on AI Server Growth, TotalEnergies Deal, and Super Micro Woes
Dell shares surged 12.6% Friday on a $100M supercomputer deal with TotalEnergies and Nvidia, while renewed scrutiny of Super Micro's legal issues boosted investor interest in Dell's AI server business.
Novavax Shares Surge on Pfizer Deal, Vaccine Strategy Shift
Novavax shares surged 13% Friday after Q1 revenue of $139.5 million beat estimates, fueled by a $30 million Pfizer licensing deal for Matrix-M adjuvant.
POET Technologies Stock Rebounds Amid Securities Lawsuit and Marvell Fallout
POET Technologies shares rebounded 14.5% to $10.97 on Friday, even as a securities lawsuit over tax disclosures and cancelled Celestial AI orders moves forward with a June 29 lead plaintiff deadline.
nLIGHT Soars on Record Defense Revenue, 55% Sales Jump
nLIGHT shares surged 10.3% after Q1 revenue jumped 55% to $80.2M, driven by record aerospace and defense sales, with the company swinging to a profit and launching its HADES laser system.